United Kingdom · Question · Written question
HL HL3404
Tixagevimab/cilgavimab
Introduced
14 November 2022
Last action
28 November 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 November 2022
Summary
To ask His Majesty's Government why, given that Evusheld has been approved for private prescription, it has not yet been approved for prescription on the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 November 2022
Written question
To ask His Majesty's Government why, given that Evusheld has been approved for private prescription, it has not yet been approved for prescription on the NHS.
Source: Lords
28 November 2022
Answer
The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is based on independent clinical advice by the multi-agency RAPID C-19 and a United Kingdom national expert policy working group, which concluded...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-11-14/HL3404
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1542091
- uk · wq-1542091 · source updated 28 November 2022